Medistep Healthcare came to market through an SME IPO that opened on 8 August 2025 and closed on 12 August 2025, and the shares listed on 18 August 2025 on NSE SME. The price band was ₹43 per share and one lot was 3000 shares, so the minimum application was ₹1,29,000. The issue size was ₹16.1 crore. The whole issue was fresh shares, so the money raised went to the company.
Cameo Corporate Services Limited was the registrar to the issue, and Fast Track Finsec Pvt Ltd was the lead manager.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Founded in June 2023, Medistep Healthcare Limited is a pharmaceutical firm that manufactures sanitary pads, energy powder, and other pharmaceutical, nutraceutical, intimate, and surgical products. They believe in quality and would like to increase their product base as a public, non-government company. The product consists of the following: Sanitary Pads: Medistep makes high-quality sanitary pads, catering to necessary feminine hygiene products. Energy Powder: The firm manufactures energy supplements that help to refresh and energize consumers. Pharmaceutical Products:
Medistep deals in the trading of a range of pharmaceutical products to provide access to life-saving drugs. Nutraceutical Products: They deal in products that incorporate nutrition and pharmacy, encouraging overall well-being. Intimate Care and Hygiene Products: The firm offers intimate care and hygiene products. Surgical Products: Medistep deals in surgical products and assists healthcare practitioners with essential equipment and instruments. As of December 30, 2024, Medistep has annualized revenues of ₹45.00 crore and Profit After Tax (PAT) of ₹4.08 crore.
As of December 28, 2024, the company has nine payroll employees. Labour requirements are subject to daily-paid labourers, and none are contractual.
As described in the offer document.
| Metric | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Girdhari Lal Prajapat, Dabhi Vipul Gobarbhai, Prajapati Hetalben Girdharilal. Promoter holding 93.62% before the issue and 68.96% after.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Medistep Healthcare IPO was a ₹16.1 crore fixed-price issue, made up entirely of a fresh issue. It was priced at ₹43 per share with a lot size of 3,000 shares; the minimum retail application was 6,000 shares (₹2,58,000). The IPO was open from August 8 to August 12, 2025 and was subscribed 80.52x. Shares listed on NSE SME on August 18, 2025 at ₹53, a 23.3% premium to the issue price of ₹43. Cameo Corporate Services Limited is the registrar.
Fast Track Finsec Pvt Ltd is the book running lead manager.
The issue price of Medistep Healthcare IPO is ₹43 per share (fixed price).
The lot size of Medistep Healthcare IPO is 3000 shares.
The minimum investment for Medistep Healthcare IPO is approximately ₹2,58,000 based on the issue price.
The allotment date of Medistep Healthcare IPO is Aug 13, 2025.
Medistep Healthcare IPO's final recorded GMP before listing was ₹8 per share (a 19% premium over the ₹43 upper price band). The shares listed at ₹53. GMP is unofficial and does not forecast or guarantee the actual listing price.
You can check Medistep Healthcare IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Medistep Healthcare IPO allotment status on Rupix for quick and easy access.
₹43 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 3000 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,29,000. After listing, SME shares also trade in lots rather than one share at a time.
₹1,29,000, for one lot of 3000 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 8 August 2025 and closed on 12 August 2025.
The basis of allotment was published on 13 August 2025 by Cameo Corporate Services Limited, and allotted shares were credited to demat accounts before listing.
The shares listed on 18 August 2025 on NSE SME.
The issue size was ₹16.1 crore. The fresh issue was 37,44,000 shares (aggregating up to ₹16.1 crore).